Iodide

Iodide

SCHEMBL285057

CC[n+]1ccccc1/C=C/c1ccc(N(C)C)cc1.[I-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.50
MEN1 O00255 10/20 1.00
KMT2A Q03164 10/20 1.00
RAB9A P51151 8/20 1.00
NPC1 O15118 6/20 1.00
HTT P42858 5/20 1.00
MAPT P10636 5/20 1.00
ALDH1A1 P00352 4/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
STAT3 P40763 1/20 1.00
KDM4A O75164 5/20 0.72
KDM2A Q9Y2K7 5/20 0.72
APOBEC3A P31941 3/20 0.70
APOBEC3G Q9HC16 3/20 0.70
GFER P55789 3/20 0.70
LMNA P02545 4/20 0.59
NPSR1 Q6W5P4 4/20 0.59
POLB P06746 3/20 0.59
THRB P10828 3/20 0.59
PPARG P37231 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL29837406 1.00 MEN1 (1.00) MEN1KMT2ARAB9ANPC1HTT
Iodide SCHEMBL285058 1.00 MEN1 (1.00) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3870022 0.98 MEN1 (0.97) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3385183 0.98 MEN1 (0.97) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL140215 0.90 KMT2A (0.82) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL29681553 0.90 KMT2A (0.82) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL140214 0.90 KMT2A (0.82) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL21005773 0.87 KDM4A (0.81) MEN1KMT2ARAB9ANPC1HTT
Iodide SCHEMBL7024146 0.87 MEN1 (0.77) MEN1KMT2ARAB9ANPC1HTT
Iodide SCHEMBL7024143 0.87 MEN1 (0.77) MEN1KMT2ARAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014122370-A1 METHOD FOR PURIFYING CELLS SCHUSSLER OLIVIER (FR) 2014-08-14 WO claimed
US-20140120564-A1 NON-INVASIVE MEASUREMENT OF ANALYTES CERCACOR LABORATORIES, INC. (US) 2014-05-01 US claimed
US-8509867-B2 Non-invasive measurement of analytes CERCACOR LABORATORIES, INC. (US) 2013-08-13 US claimed
US-20070020181-A1 Non-invasive measurement of analytes CERCACOR LABORATORIES, INC. 2007-01-25 US claimed
EP-1200051-B1 AGENT FOR DYING KERATIN FIBERS HENKEL KGAA (DE) 2006-02-01 EP claimed
US-6966213-B2 Rapid method for detecting leaks of hydraulic fluids in production plants NALCO COMPANY (US) 2005-11-22 US claimed
US-20050160795-A1 Rapid method for detecting leaks of hydraulic fluids in production plants ECOLAB USA INC. 2005-07-28 US claimed
US-20040106163-A1 Non-invasive measurement of analytes MASIMO LABORATORIES, INC. 2004-06-03 US claimed
WO-2004044557-A2 NON-INVASIVE MEASUREMENT OF ANALYTES ARGOSE, INC. (US) 2004-05-27 WO claimed
US-4362645-A Temperature indicating compositions of matter AKZONA, INC. (US) 1982-12-07 US claimed
US-4345470-A All plastic disposable thermometer AKZONA INCORPORATED (US) 1982-08-24 US claimed
US-4339207-A Temperature indicating compositions of matter AKZONA INCORPORATED (US) 1982-07-13 US claimed
US-12318391-B2 Methods and compositions for the prevention and treatment of hearing loss ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 2025-06-03 US disclosed
CN-119424333-A Application of antioxidant liposome in preparation of medicine for preventing and/or treating inner ear injury caused by active oxygen accumulation 华中科技大学同济医学院附属协和医院 2025-02-14 CN disclosed
EP-3786164-B1 METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF HEARING LOSS TING THERAPEUTICS LLC (US) 2024-08-14 EP disclosed
CN-112933094-B Methods and compositions for preventing and treating hearing loss 听治疗有限责任公司 2024-07-26 CN disclosed
US-4397570-A HIGH SPEED REVERSING; RETENTION OF LOW-TEMPERATURE PROPERTIES PYMAH CORPORATION (US) 1983-08-09 US disclosed
US-4362645-A Temperature indicating compositions of matter AKZONA, INC. (US) 1982-12-07 US disclosed
US-4339207-A Temperature indicating compositions of matter AKZONA INCORPORATED (US) 1982-07-13 US disclosed
US-4232552-A THERMOCHROMISM, DISPOSABLE THERMOMETERS AKZONA INCORPORATED (US) 1980-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12318391-B2 Methods and compositions for the prevention and treatment of hearing loss CDK2, CDK5, CDK20 ACHE 2258/4885MEN1 875/4885KMT2A 2582/4885
US-20070020181-A1 Non-invasive measurement of analytes SLC2A3, SLC2A2, SLC2A4 ACHE 1971/4885MEN1 419/4885KMT2A 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.